Skip to content

A cohort study of the target protein as a novel follow-up tumor marker for patients with ovarian clear cell carcinoma after surgery

A cohort study of the target protein as a novel follow-up tumor marker for patients with ovarian clear cell carcinoma after surgery - A cohort study of a novel ovarian CCC tumor marker

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000024545
Enrollment
30
Registered
2016-10-27
Start date
2016-10-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian cancer

Interventions

None listed

Sponsors

Yokohama City University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Patinets whose pre-treatment serum samples are obetained. 2.Patients who submitted the documment for written informed consent

Exclusion criteria

Exclusion criteria: 1. Patients who are judged as being inappropriate for this study 2. Patients during pregnancy

Design outcomes

Primary

MeasureTime frame
Changes in serum concentrations of target protein and CA125 before and after treatment

Secondary

MeasureTime frame
Complementaly effects of the target protein and CA125

Countries

Japan

Contacts

Public ContactRuiz Yokota Naho

Yokohama City University Department of Obstetrics and Gynecology

nhyokota@yokohama-cu.ac.jp045-787-2800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026